Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
Surgery Today|November 11, 2011
Successful surgical treatment of advanced follicular thyroid carcinoma with tumor thrombus infiltrating the superior vena cava: report of a caseNaoyoshi Onoda, Masanori Nakamura, Mitsuharu Hosono, et al.Journal of Medical Case Reports|February 19, 2014
A rare recurrence of bilateral breast cancer in the esophagus coincidentally associated with primary gastric cancer: a case reportShinichiro Kashiwagi, Naoyoshi Onoda, Yuka Asano, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2021
[A Case of Hepatectomy for Primary Hepatic Neuroendocrine Tumor, Preoperatively Diagnosed with Hepatocellular Carcinoma]Naoki Tani, Takeshi Hori, Nozomi Iimori, et al.Breast Cancer Research : BCR|December 1, 2011
Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67Shinichiro Kashiwagi, Masakazu Yashiro, Tsutomu Takashima, et al.International Journal of Molecular Medicine|November 13, 2003
Identification of a trypsinogen activity stimulating factor produced by pancreatic cancer cells: its role in tumor invasion and metastasisYasutake Uchima, Tetsuji Sawada, Tamahiro Nishihara, et al.Surgery Today|April 27, 2004
Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroidNaoyoshi Onoda, Kana Ogisawa, Tetsuro Ishikawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 28, 2005
[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen]Tsutomu Takashima, Bunzo Nakata, Masahiro Komoto, et al.Oncology Reports|April 17, 2002
Prognostic value of combined analysis of estrogen receptor status and cellular proliferative activity in breast cancer patients with extensive lymph node metastasesTsutomu Takashima, Naoyoshi Onoda, Tetsuro Ishikawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[A Case of Paget-Type Recurrence 20 Years after Breast Conserving Surgery for Invasive Ductal Carcinoma]Tomohiro Lee, Hidemi Kawajiri, Bunzo Nakata, et al.Plos One|October 11, 2012
CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancerNaoki Aomatsu, Masakazu Yashiro, Shinichiro Kashiwagi, et al.Pageof 11